Optimistic about Agenus' BOT/BAL program in MSS colorectal cancer? Learn how clinical potential, cost cuts, and risks shape ...

Audits of the non-surgical cosmetics industry are under way to check compliance with legislation at both state and federal ...

PIMCO Income Strategy Fund II offers a high 11.9% yield with broad debt diversification. Find out why I think PFN's high rates and dividend risks limit upside.

Some portfolio managers say the cure for the company’s woes is time and contrarian courage.

Q1 2025 Earnings Call Transcript May 16, 2025 Operator: Good day and welcome to the Abeona Therapeutics First Quarter 2025 ...

Q1 2025 Earnings Call Transcript May 15, 2025 Omeros Corporation misses on earnings expectations. Reported EPS is $-0.65 EPS, expectations were $-0.57. Jennifer Williams – Investor and Media relations ...

Interim Jan-2025 results from three trials of Alpha DaRT® in treating pancreatic cancer shared at prestigious 2025 ASCO GI Symposium and ...

Beyond 2027, Idorsia aims to continue the sales trajectory of QUVIVIQ with a stable OPEX, leading to higher sustainable ...

U.S. FDA clears lung cancer IND for CVHNLC, a proprietary off-the-shelf candidate targeting squamous non-small cell lung ...

Shares of Hinge Health jumped 22% above the initial public offering price in the company's New York Stock Exchange debut ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

Invivyd plans to advance next generation COVID-19 mAbs to improve product scalability and system-friendliness while preserving strong anticipated mAb preventative efficacy; additional data on ...